Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.
|Original language||English (US)|
|Number of pages||3|
|Journal||Journal of drugs in dermatology : JDD|
|State||Published - Jan 1 2005|
ASJC Scopus subject areas